Palmitoyl Tetrapeptide-7 is a synthetic messenger peptide designed to suppress the production of excess interleukins, which are chemical messengers that trigger chronic inflammatory responses in the skin. By reducing these pro-inflammatory signals, the peptide slows the degradation of the extracellular matrix and helps preserve the structural integrity of collagen and elastin fibers.
- INCI Name:
- Palmitoyl Tetrapeptide-7
- Chemical/Scientific Name:
- N-Palmitoyl-Gly-Gln-Pro-Arg
- Common Aliases:
- Pal-GQPR, Palmitoyl Tetrapeptide-3 (former name), Rigin
| Category: | Active Substances |
| Source Origin: | Synthetic |
| Comedogenic Rating: | 0 |
| Primary Industries: | Cosmetics, Dermatology |
| Solubility: | Oil-dispersible/Glycol-soluble |
At a Glance: Properties & Effects
| Anti-Aging/Renewal: | |
| Soothing/Calming: | |
| Barrier Repair: | |
| Irritation Risk: |
Primary Benefits:
- Inhibits glycation-induced damage and inflammation
- Enhances skin firmness and elasticity
- Reduces under-eye puffiness and dark circles
- Supports long-term dermal structural repair
Potential Risks:
- Minimal risk of localized sensitivity
- Requires consistent use for cumulative results
Biological Action & Cosmetic Profile
Research indicates that this peptide functions as a fragment of immunoglobulin G, effectively mimicking natural biological signals that regulate inflammation. It specifically targets Interleukin-6 (IL-6), a cytokine that typically increases with age and environmental stress. When IL-6 levels are elevated, the skin’s repair mechanisms are compromised, leading to a phenomenon known as “inflammaging” where chronic low-grade inflammation accelerates collagen breakdown. By modulating this pathway, the tetrapeptide helps maintain a calmer cellular environment conducive to protein synthesis.
Formulations often combine this ingredient with Palmitoyl Tripeptide 1 to create the proprietary complex known as Matrixyl 3000. While the tripeptide stimulates the production of new dermal components, the tetrapeptide focuses on protecting existing structures from enzymatic degradation. This dual-action approach addresses both the depletion of collagen and the prevention of its loss, resulting in measurable improvements in wrinkle depth and skin roughness.
Penetration through the stratum corneum is facilitated by the attachment of Palmitic Acid to the peptide’s amino acid chain. This lipid tail increases the molecule’s lipophilicity, allowing it to bypass the skin’s surface barrier more effectively than water-soluble Amino Acids alone. Once absorbed, it signals fibroblasts to remain in a more active, youthful state of extracellular matrix maintenance.
Broader Applications & Origins
The synthesis of this ingredient involves lab-controlled sequences of glycine, glutamine, proline, and arginine. Because it is bio-identical to fragments already found in human systems, the skin recognizes the signal without initiating an immune defense response. Beyond general anti-aging serums, it is a staple in eye contour treatments where it helps alleviate the vascular and inflammatory components of dark circles.
Standard raw material forms typically disperse the peptide in a base of Glycerin and Butylene Glycol to ensure stability and ease of incorporation into emulsions. Preservative systems like Ethylhexylglycerin and Caprylyl Glycol are frequently used in these commercial peptide blends to maintain microbial purity.
Routine Integration
Synergies:
- Niacinamide: Enhances barrier function while the peptide targets deeper dermal signals.
- Sodium Hyaluronate: Provides surface hydration to complement the peptide’s structural benefits.
- Ascorbic Acid: Acts as a cofactor for collagen synthesis, boosting the peptide’s efficacy.
Conflicts:
- Highly acidic formulations (pH < 3.5): May theoretically hydrolyze the peptide bonds over long periods of storage, though modern stabilized versions are generally resilient.
Clinical Consensus & Safety
The Cosmetic Ingredient Review (CIR) Expert Panel has evaluated Palmitoyl Tetrapeptide-7 and concluded it is safe for use in cosmetic concentrations, typically ranging from 0.001% to 0.01% in finished products. Toxicological assessments show no evidence of mutagenicity, systemic toxicity, or significant dermal irritation. Peer-reviewed clinical studies have demonstrated that regular application twice daily for 12 weeks leads to a statistically significant reduction in wrinkle surface area and improved skin tonicity.
Is it effective for reducing under-eye puffiness?
Yes, clinical data suggests that by reducing inflammatory markers and improving lymphatic drainage signaling, this peptide can help minimize the appearance of fluid retention and swelling around the eyes.
Can it be used alongside retinol?
This peptide is frequently paired with retinoids to mitigate the irritation and inflammation often associated with vitamin A, as its soothing properties help balance the skin’s tolerance while providing complementary anti-aging benefits.
How long before I see visible results?
While individual results vary, most clinical trials show measurable improvements in skin firmness and wrinkle reduction after 4 to 8 weeks of consistent, twice-daily application.